Sign in

Ramiro Peru

Independent Chair of the Board at Elevance Health
Board

About Ramiro G. Peru

Independent director of Elevance Health (ELV) since 2004; appointed to become Independent Chair of the Board effective at the May 14, 2025 Annual Meeting. Former public-company CFO (Phelps Dodge; Swift Transportation) with deep finance and capital markets expertise, plus oversight experience spanning information systems/technology and human resources; age 69; B.S., University of Arizona. Currently chairs ELV’s Compensation & Talent Committee and serves on the Finance Committee; the Board has determined he is independent under NYSE and SEC standards.

Past Roles

OrganizationRoleTenureCommittees/Impact
Phelps Dodge CorporationExecutive Vice President & Chief Financial Officer; prior finance/accounting roles1979–2007 (CFO 1999–2007)Senior VP responsibilities included managing information systems/technology and human resources; brings operating/technology oversight to boardroom.
Swift CorporationExecutive Vice President & Chief Financial OfficerJun–Dec 2007Public-company CFO experience in transportation/logistics.

External Roles

OrganizationRoleTenurePublic/PrivateNotes
SM Energy CompanyDirectorSince 2014PublicCurrent public company directorship.
UNS Energy Corporation (subsidiary of Fortis Inc.)DirectorSince 2007Private (public until Aug 2014)Long-standing utility governance experience.
bluemedia, Inc.Director2018–2023PrivateLarge-format printing company.
WellPoint Health Networks, Inc.Director2003–2004Public (historical)Historical link to ELV predecessor.

Board Governance

  • Board role and independence: Incoming Independent Chair (effective May 14, 2025); ELV maintains separate Chair/CEO roles; 10 of 11 directors are independent (all except the CEO).
  • Committee assignments: Chair, Compensation & Talent Committee; Member, Finance Committee.
  • Meeting cadence and attendance: 2024 Board meetings (6); independent directors hold executive sessions at the beginning and end of each regularly scheduled Board meeting; each director attended ≥75% of Board and applicable committee meetings in 2024.
  • Committee meeting counts (2024): Audit (8), Compensation & Talent (4), Governance (4), Finance (7).
  • Evaluation, refreshment, leadership: Annual Board/committee/individual director evaluations facilitated by an external party; mandatory retirement age policy; Peru succeeds the retiring Chair in 2025.
  • Risk and oversight: As Compensation & Talent Chair, Peru oversees pay risk reviews, executive pay decisions, talent management and inclusion; the committee uses an independent consultant (WTW), assessed annually for independence.

Fixed Compensation (Non-Employee Director – 2024)

ComponentAmountDetail
Annual cash retainer$125,000Standard non-employee director cash retainer.
Committee chair retainer$30,000Compensation & Talent Committee Chair.
Fees earned or paid in cash (reported)$155,484Includes $483.88 paid in cash in lieu of fractional share.
Annual equity grant (deferred shares) – value$209,516388 deferred shares granted on Annual Meeting date; shares deferred for min. 5 years; dividend equivalents accrue during deferral.
All other compensation$27,613Includes dividend equivalents ($17,613) and eligibility for foundation matching gifts up to $10,000.
Total 2024 director compensation$392,613Sum of cash, equity grant value and other compensation.

Additional policy notes:

  • Non-Executive Chair retainer: $260,000 (applies when serving as Chair; ELV maintains separate Chair/CEO).
  • Director equity grant mechanics: 388 deferred shares in 2024 based on $539.99/share; distribution after 5-year minimum deferral or upon Board departure.

Performance Compensation

  • Non-employee directors at ELV do not receive performance-based incentive pay; compensation is a mix of cash retainers and time-deferred stock awards. No director options outstanding.
  • For context on Peru’s oversight as Compensation & Talent Chair, ELV’s 2024 executive AIP metrics and results were as follows:
Performance MeasureTargetActual 2024 Performance
Adjusted Net Income$8,644 millionMissed threshold: $7,677 million (adjusted).
Operating Revenue$170,200 millionExceeded target: $173,349 million (adjusted).
Improving the Health of Humanity (3 sub-metrics)VariousOverall above target (2 of 3 metrics above target).
Star Ratings+33.5 pp vs. 2023Missed threshold: −2.0 pp vs. 2023.
Consumer Effort+2.0 pp vs. 2023Missed target: +1.9 pp vs. 2023.
  • Relative peer modifier for AIP funding set at 92.5% based on relative Adjusted Net Income growth and Total Revenue growth vs. industry peers.

Other Directorships & Interlocks

  • Current public company board: SM Energy Company (Director since 2014).
  • Compensation committee interlocks: None; during 2024, no ELV executive served on a board or comp committee of another company that had an executive serving on ELV’s Board/Compensation & Talent Committee.
  • Related person transactions: None involving Compensation & Talent Committee members required disclosure under Item 404 in 2024; ELV’s related-person transaction policy requires Governance Committee review/approval and prohibits transactions inconsistent with shareholder interests.

Expertise & Qualifications

  • Finance and capital markets leadership as CFO at two public companies (Phelps Dodge; Swift).
  • Technology and operations oversight experience (managed information systems/technology; board service at an oil & gas E&P with technology oversight).
  • Committee leadership (Compensation & Talent Chair) and incoming Independent Chair—strong governance credentials.
  • Education: B.S., University of Arizona.

Equity Ownership

HolderShares OwnedDeferred SharesTotal Beneficial OwnershipNotes/Date
Ramiro G. Peru6,2672,4778,744Beneficial ownership as of Feb 1, 2025; none of ELV’s directors/NEOs owns ≥1% of shares outstanding.
Director deferred shares outstanding2,477As of Dec 31, 2024, Peru held 2,477 deferred shares under the Board Deferred Compensation Plan.
Ownership guidelinesDirectors must own ≥$625,000 in ELV stock within 5 years; all directors meet or are on track (based on 2024 average price $494.48).
  • Prohibitions on hedging/pledging of ELV stock apply to directors and executive officers.

Governance Assessment

  • Positive signals

    • Independent Board leadership: Separation of Chair/CEO; Peru appointed Independent Chair in 2025; robust independence (10/11 independent directors).
    • Strong compensation governance under Peru’s committee: independent consultant; rigorous AIP and PSU frameworks; clawback policy includes both mandatory restatement-based recovery and discretionary recoupment for misconduct/reputational harm.
    • Shareholder alignment: Annual say-on-pay with strong 2024 support (~92% “for”).
    • Board effectiveness: External-facilitated annual evaluations (board/committee/individual); regular executive sessions; defined committee charters and active meeting cadence.
    • Compliance/ethics: Section 16 filings timely for directors/NEOs (one late Form 4 for a former executive officer due to administrative error).
  • Watch items

    • Consultant conflicts optics: While the Compensation & Talent Committee’s independent advisor (WTW) was deemed independent, ELV and subsidiaries paid WTW and/or subsidiaries ~$177.5 million in 2024 for non-executive services (insurance brokering/marketing), though this represented <2% of WTW parent revenue; continued monitoring advisable.
    • Medicare Star Ratings headwind in 2024 (fell vs. 2023), contributing to below-target AIP funding; oversight focus on remediation remains important.
  • Structural protections

    • No option/SAR repricing without shareholder approval; no change-in-control excise tax gross-ups; double-trigger CIC; anti-hedging/pledging; proxy access; majority voting in uncontested director elections; commitment to declassify if BCBSA requirement ends.
  • Attendance/engagement

    • 2024 attendance at least 75% for all directors; Board met 6x; Peru’s committees met regularly (Compensation & Talent 4x; Finance 7x).